High-Grade Serous Ovarian Cancer during Pregnancy: From Diagnosis to Treatment

Curr Oncol. 2024 Apr 2;31(4):1920-1935. doi: 10.3390/curroncol31040144.

Abstract

Background: Due to the rarity of ovarian cancer diagnosed during pregnancy, the literature on the treatment of subtypes of epithelial ovarian cancer in pregnancy is sparse. The aim of our review was to analyze cases of high-grade serous ovarian cancer in pregnancy.

Methods: The PubMed and Scopus databases were searched for relevant articles published in English between January 2000 and December 2023. The references of all the relevant reviews found were also checked to avoid omitting eligible studies. Information on the all retrieved cases was extracted and reviewed in detail. The most important detail was the subtype of high-grade serous ovarian cancer, which was referred to as serous adenocarcinoma (grade 2 or grade 3) in older cases.

Results: We found eleven cases with relevant details of high-grade serous ovarian cancer diagnosed in pregnancy. Despite the small number of cases we found, our study demonstrated the importance of an accurate initial vaginal ultrasound at the first examination in pregnancy and the safety of diagnostic surgery and chemotherapy in pregnancy.

Conclusions: There have not been long-term follow-ups of patients' oncologic and obstetric outcomes. As patients should be comprehensively informed, more detailed case reports or series with longer follow-up periods are needed.

Keywords: cancer; chemotherapy; fetal outcome; high-grade serous ovarian cancer; ovarian cancer; pregnancy; surgery.

Publication types

  • Review

MeSH terms

  • Adult
  • Cystadenocarcinoma, Serous / therapy
  • Female
  • Humans
  • Ovarian Neoplasms* / diagnosis
  • Ovarian Neoplasms* / therapy
  • Pregnancy
  • Pregnancy Complications, Neoplastic* / therapy

Grants and funding

This research received no external funding.